As HBD2 production has been shown to be abrogated by deletion of NF-κB binding sites in the DEFB4 promoter region [28], the relative contribution of inflammation, perhaps via activation of NF-κB in IBD [32] is potentially important in the regulation of HBD2 production. This evidence concerns the gene NFKB1 and inflammatory bowel disease.